195 related articles for article (PubMed ID: 22212761)
1. Identification of F-box only protein 7 as a negative regulator of NF-kappaB signalling.
Kuiken HJ; Egan DA; Laman H; Bernards R; Beijersbergen RL; Dirac AM
J Cell Mol Med; 2012 Sep; 16(9):2140-9. PubMed ID: 22212761
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
5. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
Kang J; Chung KC
Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
[TBL] [Abstract][Full Text] [Related]
6. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
[TBL] [Abstract][Full Text] [Related]
7. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.
Varfolomeev E; Goncharov T; Fedorova AV; Dynek JN; Zobel K; Deshayes K; Fairbrother WJ; Vucic D
J Biol Chem; 2008 Sep; 283(36):24295-9. PubMed ID: 18621737
[TBL] [Abstract][Full Text] [Related]
8. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
9. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
[TBL] [Abstract][Full Text] [Related]
10. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
de Almagro MC; Goncharov T; Newton K; Vucic D
Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062
[TBL] [Abstract][Full Text] [Related]
11. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.
Rosebeck S; Rehman AO; Apel IJ; Kohrt D; Appert A; O'Donnell MA; Ting AT; Du MQ; Baens M; Lucas PC; McAllister-Lucas LM
Oncogene; 2014 May; 33(19):2520-30. PubMed ID: 23770847
[TBL] [Abstract][Full Text] [Related]
12. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling.
Dynek JN; Goncharov T; Dueber EC; Fedorova AV; Izrael-Tomasevic A; Phu L; Helgason E; Fairbrother WJ; Deshayes K; Kirkpatrick DS; Vucic D
EMBO J; 2010 Dec; 29(24):4198-209. PubMed ID: 21113135
[TBL] [Abstract][Full Text] [Related]
13. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.
Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH
J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989
[TBL] [Abstract][Full Text] [Related]
14. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.
Chang SJ; Hsiao JC; Sonnberg S; Chiang CT; Yang MH; Tzou DL; Mercer AA; Chang W
J Virol; 2009 May; 83(9):4140-52. PubMed ID: 19211746
[TBL] [Abstract][Full Text] [Related]
15. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
16. PIDD mediates NF-kappaB activation in response to DNA damage.
Janssens S; Tinel A; Lippens S; Tschopp J
Cell; 2005 Dec; 123(6):1079-92. PubMed ID: 16360037
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
[TBL] [Abstract][Full Text] [Related]
18. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
Fearns C; Pan Q; Mathison JC; Chuang TH
J Biol Chem; 2006 Nov; 281(45):34592-600. PubMed ID: 16968706
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
20. 4',6-Dihydroxy-4-methoxyisoaurone inhibits TNF-α-induced NF-κB activation and expressions of NF-κB-regulated target gene products.
Ma J; Mi C; Wang KS; Lee JJ; Jin X
J Pharmacol Sci; 2016 Feb; 130(2):43-50. PubMed ID: 26654829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]